dimly in glomeruli. In contrast, CD71 was strongly expressed in 105 of the 107 glomeruli of the kidney biopsies from the IgA-N group. For the control group, it was found that expression of CD71 in glomeruli was correlated to the presence of IgA deposits. Indeed, among the 87 glomeruli of nine kidney biopsies (eight patients) without IgA fixation, 78 exhibited no CD71 expression and nine exhibited a very dim one. On the other hand, all 49 glomeruli of the eight kidney biopsies (seven patients) in which IgA deposits were detected exhibited CD71 expression (P Ͻ 10 Ϫ4 ). Performance of dual-labeling studies with confocal microscopy on kidney biopsies of IgA-N patients demonstrated that most of the IgA deposits co-localized with CD71. It was also demonstrated that the intensity of the expression of CD71 was not linked to the intensity of clinical or biologic findings but to the intensity of cellular proliferation in both IgA-N and control groups. These results show that mesangial CD71 expression is not specific to IgA-N. However, the association between IgA deposits and CD71 expression and their co-localization in the mesangium provide strong evidence that CD71 is a major IgA receptor on mesangial cells.
Henoch-Schönlein purpura (HSP) nephritis and Berger disease are both considered as IgA nephropathy (IgA-N). Berger disease, first described by Berger and Hinglais (1) , is a mesangial proliferative glomerulonephritis defined by mesangial deposition of IgA. HSP is a systemic IgA-mediated vasculitis that usually associates skin lesions and abdominal and joint pains (2) . About 30% of the HSP patients present with glomerular lesions (3) (4) (5) (6) (7) that are characterized, like in Berger disease, by mesangial deposition of IgA. It has been suggested that Berger disease and HSP are pathogenetically linked and that Berger disease could be a kidney-restricted form of HSP. Indeed, kidney lesions are indistinguishable (8) , and, in both disorders, many patients have increased serum IgA levels (9 -11) and IgA containing circulating immune complexes (CIC) (11, 12) . Whatever the mechanism(s) involved in the pathogenesis of these two diseases, the final common pathway of Berger disease and HSP is represented by mesangial IgA deposition. Although it has been established that IgA could bind specifically to mesangial cells and induce proliferation and cytokine production (13) , the identity of the receptor(s) of IgA on mesangial cells remains unknown. Indeed, none of the four IgA receptors that have been identified in humans have been shown to be expressed on mesangial cells (13) (14) (15) . These include the IgA Fc receptor (Fc␣RI; CD89) expressed on myeloid cells that binds IgA1 and IgA2 (16 -19) , the polymeric-Ig receptor (pIgR) on mucosal epithelial cells (20) that binds polymeric IgA and IgM, the Fc␣/R on B cells and macrophages that also binds IgA and IgM (21) , and the asialoglycoprotein receptor (ASGP-R) on hepatocytes that can bind glycoproteins, including IgA1 and IgA2 through terminal galactose or N-acetylgalactosamine on O-linked and some N-linked glycans. Recently, our group has characterized a new receptor for IgA1 that, in contrast to Fc␣RI, is not expressed on leukocytes but on mesangial cells (22) . This receptor, identified as the transferrin receptor (TfR or CD71), binds IgA1 but not IgA2 (22) . We proposed that this receptor could have IgA1 as a ligand in IgA-N and showed that this receptor was expressed in the glomeruli of three Berger disease patients (22) . To assess whether this mesangial IgA1 receptor was involved in the fixation of IgA on mesangial cells and whether it was specific of IgA-N, we analyzed its expression on kidney biopsies of 16 children with Berger disease or HSP in comparison with kidney biopsies of 15 children with other glomerular diseases and with normal kidney specimens from children with nephroblastoma. We also investigated whether the expression of CD71 in IgA-N could be correlated to the severity of the nephritis as defined by clinical, biologic, or histopathologic features.
Materials and Methods

Patients and Tissue Samples
We retrospectively analyzed 16 kidney biopsies of 16 patients with HSP (n ϭ 12) or Berger disease (n ϭ 4). This group was called IgA-N group. These biopsies were compared with 17 kidney biopsies of 15 patients with systemic lupus erythematosus (n ϭ 6), poststreptococcal acute glomerulonephritis (n ϭ 3), type I membranoproliferative glomerulonephritis (n ϭ 1), steroid-sensitive idiopathic minimal change nephrotic syndrome (n ϭ 1), steroid-resistant idiopathic nephrotic syndrome with focal and segmental glomerulosclerosis (n ϭ 1), and persistent and isolated proteinuria with minimal change lesions (n ϭ 3). This second group was called control group. For these two groups, renal tissue samples were obtained by percutaneous needle biopsy taken on clinical indications from children who were treated during the years 1995 to 2001 in the Nephrology Unit of Hopital Robert Debre, Paris, France. We also retrospectively analyzed five kidney samples from nephrectomy specimens from children with nephroblastoma. Sections were performed far away from the tumoral tissue, and the histopathologic analysis of these sections was considered normal. Each section contained hundreds of glomeruli, but only 50 glomeruli per patient were counted and analyzed because the aspect was homogenous. This group was called normal group.
Diagnosis of HSP relied on the association of joint pain, abdominal pain, and purpura with normal platelet counts. All patients with Berger disease had repeated macroscopic hematuria. In all cases, the diagnosis was confirmed by kidney biopsy showing the presence of mesangial IgA deposits. The main clinical and biologic characteristics of these 16 patients at the time of kidney biopsy are given in Table 1 . Diagnoses in control group patients were based on typical clinical and biologic findings and on kidney histology on which light microscopy and immunofluorescence staining for immunoglobulins and complement components had been performed.
All biopsies were re-analyzed by conventional light microscopy. Patients from IgA-N group were graded according to the classification of the International Study of Kidney Disease in Childhood (ISKDC) modified by Heaton et al. (23) for HSP nephritis and according to the classification proposed by Haas (24) for Berger disease.
In all cases, frozen biopsies were available. These frozen sections were analyzed for IgA deposition and CD71 expression. In all cases, glomeruli available on frozen samples were quantified and analyzed and compared with glomeruli available on light microscopy.
Immunohistochemical Studies
In each case, one fragment of the renal biopsy was immediately frozen in liquid nitrogen, embedded in Tissue-Teck O.C.T Coump 
Co-Localization of CD71 and IgA by Confocal Microscopy
Briefly, each frozen section was incubated with a mouse IgG2a anti-human CD71 monoclonal antibody (1:50 for 1 h), rinsed in Tris, and then incubated with an anti-mouse Texas red-conjugated goat antibody (1:100 for 1 h), rinsed in Tris, and finally incubated with an anti-IgA FITC-conjugated rabbit polyclonal antibody (1:10, 30 min). Omission of the anti-CD71 MoAb was used as a negative control (no Texas red fluorescence). Sections were examined with a ZEISS LSM 510 laser scan microscope using a ϫ63 objective with two lasers (argon and helium-neon). The Texas red fluorophore was visualized with the 543-nm excitation wavelengh of a helium-neon laser and FITC with the 488-nm excitation wavelength of an argon laser.
Quantification of CD71 Expression and Grading of Histologic Findings
The IgA staining was defined as absent or present. The intensity of CD71 expression was classified as absent, low (grade 1), moderate (grade 2), or high (grade 3). This semi-quantitative grading scale used for CD71 expression was based on the surface of glomerular tuft area staining positively for CD71 (see Figures 1 and 2 ). The glomeruli of frozen samples were assigned as normal, increased mesangial matrix (mesangiopathic glomeruli), or proliferative (endocapillary or extracapillary proliferation).
Statistical Analyses
Data were expressed as frequency. Comparisons used 2 test. All tests were two-tailed, and P Ͻ 0.05 was considered statistically significant. All statistical analyses were performed using SAS 8.0 (SAS Inc, Cary, NC) software package for PC computer.
Results
Association between IgA Deposits and CD71 Expression
In the normal kidney, CD71 was found to be expressed on tubular epithelium (Figure 1 ). In the glomeruli (n ϭ 250), CD71 expression was either not detected (grade 0, Figure 1A ) or found with a very dim expression (grade 1, Figure 1B ). As expected, no IgA deposits were found in these glomeruli.
In the 16 kidney biopsies of the 16 patients from IgA-N group, CD71 was markedly expressed in the mesangial area in all glomeruli (n ϭ 107). As shown in Table 2 , among these 107 glomeruli, CD71 expression was high (grade 3) in 51 glomeruli ( Figure 2B ), moderate (grade 2) in 54 ( Figure 2A) , and low (grade 1) in only 2. Moreover, mesangial CD71 expression was similar in Henoch-Schönlein nephritis and in Berger disease. As expected, mesangial IgA deposits were found in all 107 glomeruli of the IgA-N group.
The expression of CD71 and the presence of IgA deposits were also tested in the 17 kidney biopsies (136 glomeruli) of the 15 patients of the control group. In this group, no IgA deposits could be found in nine kidney biopsies of eight patients (87 glomeruli), whereas IgA deposits were found in eight kidney biopsies of seven patients (49 glomeruli). Review of the medical records of these seven patients with IgA deposits on kidney biopsy confirmed that none of them could be considered as an atypical presentation of IgA nephropathy. These seven patients with IgA deposition in control group suffered from systemic lupus erythematosus (n ϭ 5), acute poststreptococcal glomerulonephritis (n ϭ 1), and steroid-resistant idiopathic nephrotic syndrome with focal and segmental glomerulosclerosis (n ϭ 1). The eight other patients from the control group who had no IgA deposits on kidney biopsy suffered from systemic lupus erythematosus (n ϭ 1), acute poststreptococcal glomerulonephritis (n ϭ 2), type I membranoproliferative glomerulonephritis (n ϭ 1), steroid-sensitive minimal change nephrotic syndrome (n ϭ 1), and persistent and isolated proteinuria with minimal change lesions (n ϭ 3). As shown on Table 2 , the expression of CD71 in glomeruli of patients from the control group was strongly associated to the presence of IgA deposits. Indeed, among the 87 glomeruli without IgA deposits, 78 exhibited no CD71 expression (grade 0) and 9 exhibited a low one (grade 1). On the other hand, all 49 glomeruli in which IgA deposits were detected exhibited CD71 expression that ranged from grade 2 to grade 3, demonstrating an association between the presence of IgA deposits and a grade 2 or 3 CD71 expression (P Ͻ 10 Ϫ4 , 2 test). Altogether, among the 156 glomeruli with IgA deposits (107 from the IgA-N group; 49 from the control group), 154 displayed a moderate or high expression of CD71 and 2 a low one, whereas among the 87 glomeruli without IgA deposits (all of them being from the control group), 78 had no CD71 expression and 9 a low one (P Ͻ 10 Ϫ4 , 2 test).
Co-Localization of CD71 and IgA in Glomeruli
Five kidney biopsies of IgA-N patients were used for IF analysis by confocal microscopy. Seventeen glomeruli were examined and showed the same findings. As shown on Figure  3 , most of the IgA deposits were co-localized with CD71 in mesangial regions of glomeruli. This co-localization was observed on each focal plan performed by the confocal microscope, thereby ruling out the hypothesis that this co-localization was related to an overlapping of the different plans.
Association between CD71 Expression and Severity of the Kidney Disease
To determine whether the intensity of CD71 expression was correlated with the severity of the disease in the IgA-N group, level of CD71 staining was compared with clinical and biologic findings at the time of biopsy such as serum IgA level, hematuria, proteinuria, renal insufficiency, and arterial hypertension. None of these criteria correlated with the intensity of CD71 expression. However, this kind of association was very difficult to assess because of the small number of patients and because CD71 expression was homogeneous in only 9 of the 16 patients of the IgA-N group, whereas it was very heterogeneous in 7. Indeed, for these seven patients, some glomeruli exhibited a high level of CD71 expression and other glomeruli exhibited a moderate level (Table 3) . We therefore tested whether the level of CD71 expression was linked to histopathologic findings. For this purpose, glomeruli on frozen sections were classified as normal or as showing increased mesangial matrix or showing proliferative lesions. Histologic analysis is usually difficult to perform on frozen sections; therefore, data from frozen biopsies were compared with data obtained on light microscopy. Findings were similar between frozen and fixed sections, except for patient 12 for whom histologic analysis on fixed sections showed a focal proliferative glomerulonephritis with less than 50% crescents (grade IIIa according to the classification of the ISKDC modified by Heaton et al. [23] ), whereas all glomeruli observed on frozen sections displayed proliferative lesions. The observation of a slight discrepancy between fixed and frozen sections in only one patient allowed the comparison of the CD71 expression and the histologic analysis of frozen sections, glomerulus by glomerulus. By performing this comparison, we found that the level of CD71 expression was strongly associated with the intensity of proliferation. Indeed, as shown on Table 3 , among the 107 glomeruli studied in the IgA-N group, 60 glomeruli showed only an increased mesangial matrix and 47 showed proliferative lesions, including seven with crescents. Among the 60 glomeruli with increased mesangial matrix, two glomeruli displayed a grade 1 CD71 expression, 54 displayed a grade 2 (Figure 2A) , and only four displayed a grade 3. On the other hand, all 47 glomeruli with proliferative lesions displayed a grade 3 CD71 expression ( Figure 2B ), demonstrating that the presence of proliferative lesions was associated with a grade 3 CD71 expression (P Ͻ 10 Ϫ4 , 2 test). Moreover, the seven glomeruli with crescent displayed an enhancement of CD71 expression within the crescents. Within these crescents, CD71ϩ cells were mostly epithelial cells (not shown). As shown on Figure 4 , patient 7 is representative of the heterogeneity of CD71 expression and of its linkage to the intensity of proliferation. Indeed, among the seven glomeruli available on frozen sections in this patient, four glomeruli with increased mesangial matrix exhibited a low or a grade 2 CD71 expression ( Figures 4A and 4B ) and the three glomeruli with proliferative lesions exhibited a grade 3 CD71 expression ( Figure 4C and 4D). We also tested whether this association between CD71 expression and the intensity of proliferation was observed in the 49 glomeruli of the eight kidney biopsies of the control group in which IgA deposits were detected. As shown in Table 4 , among the 23 glomeruli with proliferative lesions, 16 exhibited a grade 3 CD71 expression and seven a grade 2. On the other hand, the 24 glomeruli with minimal change lesions and the two glomeruli with segmental glomerulosclerosis all exhibited a grade 2 CD71 expression, demonstrating that proliferative lesions were associated to a higher frequency of grade 3 CD71 expression as compared with minimal change lesions (P Ͻ 10 Ϫ4 , 2 test). Among the 87 glomeruli of the control group without IgA deposits, 18 glomeruli displayed proliferative lesions, including three with crescents (Table 5) , and 69 were normal or showed minimal change lesions. Among the 18 glomeruli with proliferative lesions, CD71 expression was low (grade 1) in nine and was not detected in nine, whereas none of the 69 glomeruli that were normal or with minimal change lesions were found to express CD71. This suggests that, despite a slight reinforcement of CD71 expression, proliferative lesions in the absence of IgA deposits do not result in an enhancement of CD71 expression sufficient to make it detectable at a higher level than that observed in the normal group.
Discussion
The identification of a mesangial receptor for IgA is a crucial step for the understanding of the pathogenesis of IgA-N. We could show in a previous study that the transferrin receptor (TfR/CD71), known to bind the transferrin itself (25) and to bind the hemochromatosis protein (26) , was also an IgA1 receptor expressed on cultured mesangial cells (22) . Moreover, we had shown in this study that the mesangial cell expression of CD71 was enhanced in the glomeruli of three patients with Berger disease. To test whether this enhancement of CD71 expression was specific of IgA-N, we analyzed the expression of CD71 in kidney biopsies of children with Berger disease or HSP nephritis and compared it with that of children with other glomerular disease and with that of normal kidney. In normal kidney, CD71 was undetectable or expressed at a very low grade in glomeruli. In all 16 IgA-N patients studied, the expression of CD71 in glomeruli was enhanced as compared with that observed in glomeruli of normal kidney, confirming our first results in three adult patients with Berger disease (22) . However, we found that CD71 expression in b This 4-yr-old boy had sudden onset of idiopathic nephrotic syndrome, initially resistant to steroids but responsive to cyclosporine. Subsequently, the nephrotic syndrome was steroid-dependent and cyclosporine-dependent.
glomeruli was also enhanced in other glomerulonephritis, demonstrating that this expression was not specific of IgA-N. Nevertheless, we could show that CD71 expression was linked to the presence of IgA deposits (P Ͻ 10 Ϫ4 ) and that the intensity of CD71 expression was strongly associated with the intensity of cellular proliferation (P Ͻ 10 Ϫ4 ). Considering this second observation, one could hypothesize that CD71 expression is not correlated to the IgA deposition but is simply a marker of mesangial proliferation, which is theoretically possible because CD71 is known to be a marker of proliferation in other cellular models (27) (28) (29) (30) (31) (32) (33) (34) . Several observations make the hypothesis that CD71 is only linked to cellular proliferation very unlikely. First, among the eight patients with other glomerular diseases for whom kidney biopsies showed no IgA deposition, one patient suffered from a grade IVA systemic lupus erythematosus glomerulonephritis with endocapillary proliferation, two from a post-streptococcal acute glomerulonephritis, and one from a type I membranoproliferative glomerulonephritis. Despite the proliferative lesions that were observed in all 18 glomeruli of these four patients, CD71 expression was absent in nine and low (grade 1) in nine. Second, in patients 17, 22, and 23 from the control group with IgA deposits, grade 2 CD71 expression was observed in 26 of their 33 glomeruli, but none of these 26 glomeruli displayed proliferative lesions. Third, in the IgA-N group, grade 2 CD71 expression was also observed in the glomeruli without any proliferative lesions. All these observations strongly suggest that IgA deposition by itself is associated with an enhancement of CD71 expression and that CD71 expression is first correlated with IgA deposits. Moreover, we could demonstrate, by performing dual-labeling studies with confocal microscopy, that most of the IgA deposits did co-localize with CD71 in the mesangium. This observation is the first one, to our knowledge, showing a co-localization of IgA deposits with a presumed receptor on mesangial cells. The fact that this colocalization is observed on kidney biopsies of patients with IgA deposits is much more relevant than if it was observed on cultured mesangial cells. Altogether, the association of IgA deposits and CD71 expression and the demonstration of colocalization of IgA and CD71 strongly suggests that CD71 is a major receptor for IgA1 in mesangium. Interestingly, we could show on confocal microscopy that most of the IgA molecules but not all of them co-localized with CD71. The hypothesis of another IgA receptor cannot therefore be ruled out.
Two hypotheses could account for the fact that IgA deposition is linked to an enhancement of CD71 expression. The first hypothesis is that the primary event is an overexpression of CD71 by an unknown mechanism and that this overexpression induces a fixation of IgA. This hypothesis could account for the association of IgA deposition and CD71 expression in glomerular diseases other than IgA-N but is very unlikely in the setting of IgA-N. Indeed, most of the recent studies suggest that the primary event in IgA-N is an abnormal IgA glycosylation. It has been demonstrated that serum IgA1 display an abnormal O-glycosylation in patients with IgA-N (35-37) or HSP (38 -41) and that this abnormal glycosylation is also found in IgA deposits on mesangial cells (42) . Moreover, it has been shown that abnormal IgA glycosylation is restricted to HSP patients with nephritis while it was not observed in HSP patients without nephritis (39) . In addition, it has recently been shown that abnormally glycosylated IgA isolated from IgA-N patients significantly increased the apoptotic rate and nitric oxide synthesis activity of cultured mesangial cells, in comparison with IgA fractions isolated from controls (43) . Finally, another important result arguing for a primary event due to abnormal IgA is the relapse of IgA deposits on transplanted kidney in patients with IgA-N ( 44 -47) . The second hypothesis is that the primary event is a fixation of IgA on CD71 and that this fixation induces an upregulation of CD71 expression on the cell surface either by a redistribution of cytoplasmic CD71 or by an induction of CD71 synthesis by the cells. This upregulation of CD71 would then make the expression of CD71 detectable by our immunoperoxidase staining; in "normal" glomeruli, this technique would not be sensitive enough to detect low levels of CD71 expression. This upregulation of CD71 expression could then lead to a dramatic increase of the fixation of IgA on mesangial cells. This increase of IgA deposition could then be pathogenic or not, depending on the normality or abnormality of IgA. In the setting of IgA-N, deposition of abnormally O-glycosylated IgA would be pathogenic; in the context of other glomerulonephritis, the deposition of normally O-glycosylated IgA on mesangial cells may or may not be pathogenic.
We did not find a significant correlation between the intensity of IgA staining and the intensity of CD71 expression (data not shown). This is not surprising because a linear correlation between the extent of IgA deposits and the CD71 expression was not expected. Indeed, it is known that IgA deposits are composed of IgA-containing complexes of various sizes and composition (e.g., degree of O-glycosylation, anionic charge and multimerization of IgA) (42,48 -51) . This introduces a number of independent parameters that can vary from patient to patient and may affect not only the binding of IgA to CD71 and the ability of IgA complexes to activate mesangial cells, but also the staining of IgA by immunoperoxidase or immunofluorescence.
We did not find any association between the intensity of CD71 expression and clinical or biologic findings. However, this kind of association cannot be ruled out because of the small number of patients and because of the heterogeneity of CD71 expression in 7 of the 16 patients. However, we found that the intensity of CD71 expression was strongly associated with the presence of proliferative lesions. Moreover, we could show that this association was observed within each glomerulus taken individually in a same patient. Therefore, CD71 expression could be a good marker of proliferation in IgA-N. It has been shown that there is a fairly good relationship between the clinical pattern at onset and the renal outcome in children with HSP nephritis (3,5,52-55), but it is well known that the best predictors of renal outcome are the histologic lesions observed on renal biopsy (52, 53, (55) (56) (57) . Indeed, the percentage of glomerular crescents is the major prognosis factor; involvement of more than 50% of glomeruli is well recognized to be associated with a poor outcome in children (52, 53, (55) (56) (57) . In adults, the proportion of crescents is also a major prognosis factor, but the discriminating point may be lower than 50% (58 -61) . In the context of Berger disease, it has been shown that renal histologic lesions are of good prognostic value in children (62, 63) and in adults (24, 64, 65) . Indeed, diffuse proliferative glomerulonephritis, the extent of global glomerular sclerosis, interstitial sclerosis, and crescents were identified as markers of poor prognosis (24, 65) . Therefore, it could be interesting to determine in a prospective study whether the intensity of CD71 expression could be correlated with a poor outcome. Indeed, the fact that CD71 expression is linked to the presence of IgA deposition and that the IgA fixation on CD71 is supposed to play a role in the proliferation of mesangial cells support the hypothesis that CD71 expression could be used as a more specific tool than other histologic lesions.
These results suggest that CD71 is probably the main receptor mediating IgA deposition on mesangial cells in both types of IgA-N, Berger disease, and HSP and that the study of the interaction of IgA and CD71 and its consequences on mesangial cells deserve further study for a better understanding of the pathogenic mechanisms of IgA-N.
